Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 5
2018 4
2019 2
2020 1
2021 6
2022 6
2023 3
2024 1
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Classification of early tuberculosis states to guide research for improved care and prevention: an international Delphi consensus exercise.
Coussens AK, Zaidi SMA, Allwood BW, Dewan PK, Gray G, Kohli M, Kredo T, Marais BJ, Marks GB, Martinez L, Ruhwald M, Scriba TJ, Seddon JA, Tisile P, Warner DF, Wilkinson RJ, Esmail H, Houben RMGJ; International Consensus for Early TB (ICE-TB) group. Coussens AK, et al. Lancet Respir Med. 2024 Jun;12(6):484-498. doi: 10.1016/S2213-2600(24)00028-6. Epub 2024 Mar 22. Lancet Respir Med. 2024. PMID: 38527485 Free PMC article. Review.
T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
Musvosvi M, Huang H, Wang C, Xia Q, Rozot V, Krishnan A, Acs P, Cheruku A, Obermoser G, Leslie A, Behar SM, Hanekom WA, Bilek N, Fisher M, Kaufmann SHE, Walzl G, Hatherill M, Davis MM, Scriba TJ; Adolescent Cohort Study team; GC6-74 Consortium. Musvosvi M, et al. Nat Med. 2023 Jan;29(1):258-269. doi: 10.1038/s41591-022-02110-9. Epub 2023 Jan 5. Nat Med. 2023. PMID: 36604540 Free PMC article.
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial.
Scriba TJ, Fiore-Gartland A, Penn-Nicholson A, Mulenga H, Kimbung Mbandi S, Borate B, Mendelsohn SC, Hadley K, Hikuam C, Kaskar M, Musvosvi M, Bilek N, Self S, Sumner T, White RG, Erasmus M, Jaxa L, Raphela R, Innes C, Brumskine W, Hiemstra A, Malherbe ST, Hassan-Moosa R, Tameris M, Walzl G, Naidoo K, Churchyard G, Hatherill M; CORTIS-01 Study Team. Scriba TJ, et al. Among authors: musvosvi m. Lancet Infect Dis. 2021 Mar;21(3):354-365. doi: 10.1016/S1473-3099(20)30914-2. Epub 2021 Jan 25. Lancet Infect Dis. 2021. PMID: 33508224 Free PMC article. Clinical Trial.
BCG Revaccination for the Prevention of Mycobacterium tuberculosis Infection.
Schmidt AC, Fairlie L, Hellström E, Luabeya Kany Kany A, Middelkoop K, Naidoo K, Nair G, Gela A, Nemes E, Scriba TJ, Cinar A, Frahm N, Mogg R, Kaufman D, Dunne MW, Hatherill M; BCG REVAX Study Team. Schmidt AC, et al. N Engl J Med. 2025 May 8;392(18):1789-1800. doi: 10.1056/NEJMoa2412381. N Engl J Med. 2025. PMID: 40334156 Free PMC article. Clinical Trial.
Antigen-Specific T-Cell Activation Distinguishes between Recent and Remote Tuberculosis Infection.
Mpande CAM, Musvosvi M, Rozot V, Mosito B, Reid TD, Schreuder C, Lloyd T, Bilek N, Huang H, Obermoser G, Davis MM, Ruhwald M, Hatherill M, Scriba TJ, Nemes E; ACS Study Team. Mpande CAM, et al. Among authors: musvosvi m. Am J Respir Crit Care Med. 2021 Jun 15;203(12):1556-1565. doi: 10.1164/rccm.202007-2686OC. Am J Respir Crit Care Med. 2021. PMID: 33406011 Free PMC article.
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trial.
Luabeya AKK, Rozot V, Imbratta C, Ratangee F, Shenje J, Tameris M, Mendelsohn SC, Geldenhuys H, Fisher M, Musvosvi M, Young C, Mulenga H, Bilek N, Mabwe S, Jelsbak IM, Rodríguez E, Puentes E, Doce J, Aguilo N, Martin C, Pillay C, Tait D, Russell M, Van Der Merve A, Rutkowski K, Hunt D, Ginsberg A, Scriba TJ, Hatherill M; A050 team. Luabeya AKK, et al. Among authors: musvosvi m. Lancet Glob Health. 2025 Jun;13(6):e1030-e1042. doi: 10.1016/S2214-109X(25)00046-4. Epub 2025 Apr 15. Lancet Glob Health. 2025. PMID: 40250461 Free article. Clinical Trial.
Tuberculosis alters immune-metabolic pathways resulting in perturbed IL-1 responses.
Llibre A, Smith N, Rouilly V, Musvosvi M, Nemes E, Posseme C, Mabwe S, Charbit B, Mbandi SK, Filander E, Africa H, Saint-André V, Bondet V, Bost P, Mulenga H, Bilek N, Albert ML, Scriba TJ, Duffy D. Llibre A, et al. Among authors: musvosvi m. Front Immunol. 2022 Dec 14;13:897193. doi: 10.3389/fimmu.2022.897193. eCollection 2022. Front Immunol. 2022. PMID: 36591308 Free PMC article.
Conference report: WHO meeting summary on mRNA-based tuberculosis vaccine development.
Looney MM, Hatherill M, Musvosvi M, Flynn J, Kagina BM, Frick M, Kafuko Z, Schmidt A, Southern J, Wilder-Smith A, Tippoo P, Paradkar V, Popadić D, Scriba TJ, Hanekom W, Giersing B. Looney MM, et al. Among authors: musvosvi m. Vaccine. 2023 Nov 22;41(48):7060-7066. doi: 10.1016/j.vaccine.2023.10.026. Epub 2023 Oct 21. Vaccine. 2023. PMID: 37872013 Free article.
33 results